Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
The Oncologist|July 11, 2008
Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?Carmelo Pozzo, Carlo BaroneCancer Treatment Reviews|December 23, 2008
Recurrent disease four years after surgery and adjuvant chemotherapyCarmelo Pozzo, Carlo BaroneCancer Treatment Reviews|February 23, 2008
Advances in neoadjuvant therapy for colorectal cancer with liver metastasesCarmelo Pozzo, Carlo Barone, Nancy E KemenyRays|April 17, 2003
Biological factors and therapeutic modulation in radiotherapy of head and neck cancerGiovanna Salvi, Giovanni Almadori, Michela Quirino, et al.Drugs|November 27, 2013
Critical appraisal of ramucirumab (IMC-1121B) for cancer treatment: from benchside to clinical useGiuseppe Aprile, Marta Bonotto, Elena Ongaro, et al.Surgical Oncology|September 16, 2018
Preoperative therapy and long-term survival in gastric cancer: One size does not fit allAlberto Biondi, Annamaria Agnes, Federica Del Coco, et al.Journal of Surgical Oncology|May 1, 2020
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancerAnnamaria Agnes, Alberto Biondi, Antonio Laurino, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 29, 2006
Coronary artery spasm induced by capecitabineAlfonso Sestito, Gregory Angelo Sgueglia, Carmelo Pozzo, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 27, 2007
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapyGennaro Nuzzo, Felice Giuliante, Francesco Ardito, et al.Surgical Oncology|February 21, 2022
Enhanced recovery after surgery (ERAS) versus standard recovery for gastric cancer patients: The evidences and the issuesFausto Rosa, Fabio Longo, Carmelo Pozzo, et al.Pageof 5